A cost-effectiveness analysis of onabotulinumtoxinA for overactive bladder in patients who are inadequately managed with anticholinergic medications in Spain.

Abstract Category

Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Links
	Abstract 330
	Lower Urinary Tract Symptoms in Women 1 Scientific Podium Poster Session 20
	Wednesday 22nd October 2014
	15:30 - 15:35
	Room 3
	Overactive Bladder Incontinence Detrusor Overactivity Urgency Urinary Incontinence
	1. Fundació Puigvert, Barcelona, Spain, 2. Hospital Donostia, Gipuzkoa, Spain, 3. Hospital Universitario Ramón y Cajal, Madrid, Spain, 4. Allergan Limited, Marlow, UK, 5. Allergan, Inc., Irvine CA, USA, 6. Allergan España, Madrid, Spain, 7. La-ser Analytica, Milano, Italy, 8. La-ser Analytica, Lörrach, Germany
Presenter
C Carlos Errando-Smet Fundació Puigvert, Barcelona, Spain
Abstract PDF Edit Abstract Abstract Centre